Lista de obras - Joerg F. Schlaak - Dominio Público Uruguay

A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma

artículo científico publicado en 2013

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization

artículo científico publicado en 2013

A sensitive and specific bioassay for the detection of human interleukin-10.

artículo científico publicado en 1994

Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection

artículo científico publicado en 2011

Analysis of Gene Expression Using High-Density and IFN-γ-Specific Low-Density cDNA Arrays

article

Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders

artículo científico publicado en 2014

Anti-PR-3 antibodies induce endothelial IL-8 release

artículo científico publicado en 1999

Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice

artículo científico publicado en 2001

Arterioportal Fistula Complicating Endoscopic Retrograde Cholangiography

artículo científico publicado en 2005

Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis

artículo científico publicado en 1996

Azathioprine, Mycophenolate Mofetil, and Methotrexate Specifically Modulate Cytokine Production by T Cells

article

B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes

artículo científico publicado en 2012

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

article

CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling

artículo científico publicado en 2011

CCL5: a double-edged sword in host defense against the hepatitis C virus

artículo científico publicado en 2011

Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.

artículo científico publicado en 2002

Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma

artículo científico publicado en 2013

Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy

artículo científico publicado en 1997

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

article

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.

artículo científico publicado en 2012

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression

artículo científico publicado en 2005

Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey.

artículo científico publicado en 2009

Differential Effects of IL-10 on Proliferation and Cytokine Production of Human gamma/delta and alpha/beta T cells

article

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

artículo científico publicado en 2012

Endoscopic therapy of posttransplant biliary stenoses after right-sided adult living donor liver transplantation

artículo científico publicado en 2005

Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation.

artículo científico publicado en 2008

Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration

artículo científico publicado en 2008

Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat.

artículo científico publicado en 2010

Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma

artículo científico publicado en 2013

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

artículo científico publicado en 2009

High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV.

artículo científico publicado en 2013

How long to treat chronic hepatitis B virus infection with lamivudine?

artículo científico publicado en 2000

Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge

article

Human renal tubular epithelial cells as target cells for antibodies to proteinase 3 (c-ANCA)

artículo científico publicado en 1997

IFN-α subtypes: distinct biological activities in anti-viral therapy.

artículo científico publicado en 2013

ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV.

artículo científico publicado en 2012

Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication

artículo científico publicado en 2013

Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy

article

Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma

artículo científico publicado en 2013

Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression

artículo científico publicado en 2008

Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.

artículo científico publicado en 2013

Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells

artículo científico publicado en 1998

Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.

artículo científico publicado en 2012

Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-alpha plus ribavirin

artículo científico publicado en 2003

Irregular Cytokine Pattern of CD4+T Lymphocytes in Response toStaphylococcus aureusin Patients with Wegener's Granulomatosis

article

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

article

Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways

artículo científico publicado en 2009

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression

artículo científico

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

artículo científico publicado en 2013

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

artículo científico publicado en 2011

Mutational switch of an IL-6 response to an interferon-gamma-like response

artículo científico publicado en 2002

Mycophenolate Mofetil for Treatment of Active Inflammatory Bowel Disease: Clinical and Immunological Studies

scientific article published on 01 November 1998

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study

artículo científico publicado en 2000

No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial

artículo científico publicado en 2012

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

artículo científico publicado en 2011

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

artículo científico publicado en 2012

Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients

artículo científico publicado en 2010

Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.

artículo científico publicado en 2013

Quality of life and psychiatric complications after adult living donor liver transplantation

artículo científico publicado en 2006

Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries

artículo científico publicado en 2011

Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patient

artículo científico publicado en 2000

Resektion oder lokal-ablative Therapie bei hepatozellulärem Karzinom: welche Methode für welche Patienten?

scientific article published on 13 August 2013

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

artículo científico publicado en 2012

Role of Toll-like receptors in liver health and disease ⬇️

artículo científico publicado el 1 de noviembre de 2011

Selection of donors for adult living-donor liver donation: results of the assessment of the first 205 donor candidates

artículo científico publicado en 2008

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy

artículo científico publicado en 2012

Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.

artículo científico publicado en 2012

Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery

artículo científico publicado en 2012

Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner

artículo científico publicado en 2003

Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection

artículo científico publicado en 1994

TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro

artículo científico publicado en 2013

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

artículo científico publicado en 1998

The early immune response in the liver of BALB/c mice infected with S. typhimurium

artículo científico publicado en 2000

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

artículo científico publicado en 2010

The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response

article

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

artículo científico publicado en 2009

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

artículo científico publicado en 2009

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

artículo científico publicado en 2007

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

artículo científico publicado en 2008

Tri-Iodothyronine as a Stimulator of Liver Regeneration after Partial and Subtotal Hepatectomy

artículo científico publicado en 2007

Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis

article

VEGF is important for early liver regeneration after partial hepatectomy.

artículo científico publicado en 2007

Vascular endothelial growth factor does not improve liver regeneration and survival after 90% subtotal liver resection.

artículo científico publicado en 2007

Vascular endothelial growth factor improves liver regeneration and survival after 90% hepatectomy in a rat model of diet-induced steatosis

artículo científico publicado en 2013

[Impressive picture of a melanosis coli after chronic anthraquinone laxative use--is there an increased risk for colorectal cancer?].

artículo científico publicado en 2009

Lista de obras de Joerg F. Schlaak

A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization

A sensitive and specific bioassay for the detection of human interleukin-10.

Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection

Analysis of Gene Expression Using High-Density and IFN-γ-Specific Low-Density cDNA Arrays

Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders

Anti-PR-3 antibodies induce endothelial IL-8 release

Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice

Arterioportal Fistula Complicating Endoscopic Retrograde Cholangiography

Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis

Azathioprine, Mycophenolate Mofetil, and Methotrexate Specifically Modulate Cytokine Production by T Cells

B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling

CCL5: a double-edged sword in host defense against the hepatitis C virus

Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.

Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma

Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression

Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey.

Differential Effects of IL-10 on Proliferation and Cytokine Production of Human gamma/delta and alpha/beta T cells

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

Endoscopic therapy of posttransplant biliary stenoses after right-sided adult living donor liver transplantation

Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation.

Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration

Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat.

Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV.

How long to treat chronic hepatitis B virus infection with lamivudine?

Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge

Human renal tubular epithelial cells as target cells for antibodies to proteinase 3 (c-ANCA)

IFN-α subtypes: distinct biological activities in anti-viral therapy.

ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV.

Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication

Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy

Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma

Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression

Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.

Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells

Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.

Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-alpha plus ribavirin

Irregular Cytokine Pattern of CD4+T Lymphocytes in Response toStaphylococcus aureusin Patients with Wegener's Granulomatosis

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.

Mutational switch of an IL-6 response to an interferon-gamma-like response

Mycophenolate Mofetil for Treatment of Active Inflammatory Bowel Disease: Clinical and Immunological Studies

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study

No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients

Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.

Quality of life and psychiatric complications after adult living donor liver transplantation

Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries

Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patient

Resektion oder lokal-ablative Therapie bei hepatozellulärem Karzinom: welche Methode für welche Patienten?

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

Role of Toll-like receptors in liver health and disease ⬇️

Selection of donors for adult living-donor liver donation: results of the assessment of the first 205 donor candidates

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy

Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.

Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery

Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner

Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection

TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

The early immune response in the liver of BALB/c mice infected with S. typhimurium

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.